KALA
Price:
$6.24
Market Cap:
$28.77M
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent corneal epithelial defects; EYSUVIS for the short-term treatment of the signs and symptoms of dry eye disease; and INVELTYS, a topical twice-a-day ocular steroid for the treatment of post-operative inflammation and pain following ocular surgery. Its preclinical development products comprise KPI-287 that inhibits the vascular endothelial and platelet ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2017-07-20
Stock Exchange
NASDAQ
Ticker
KALA
According to Kala Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.53. This represents a change of -8.14% compared to the average of -0.58 of the last 4 quarters.
The mean historical PE Ratio of Kala Pharmaceuticals, Inc. over the last ten years is -27.11. The current -0.53 PE Ratio has changed 95.52% with respect to the historical average. Over the past ten years (40 quarters), KALA's PE Ratio was at its highest in in the September 2022 quarter at 0.14. The PE Ratio was at its lowest in in the September 2017 quarter at -10.12.
Average
-27.11
Median
-0.88
Minimum
-260.14
Maximum
-0.11
Discovering the peaks and valleys of Kala Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 50.12%
Maximum Annual PE Ratio = -0.11
Minimum Annual Increase = -99.84%
Minimum Annual PE Ratio = -260.14
Year | PE Ratio | Change |
---|---|---|
2023 | -0.40 | -99.84% |
2022 | -260.14 | 50.12% |
2021 | -0.52 | -83.66% |
2020 | -3.17 | 156.15% |
2019 | -1.24 | -36.86% |
2018 | -1.96 | -35.17% |
2017 | -3.02 | 2.55% |
2016 | -0.11 | -49.70% |
2015 | -0.23 | -17.05% |
2014 | -0.27 | -44.98% |
The current PE Ratio of Kala Pharmaceuticals, Inc. (KALA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-87.02
5-year avg
-53.09
10-year avg
-27.11
Kala Pharmaceuticals, Inc.’s PE Ratio is less than Mallinckrodt plc (-0.04), less than Lifecore Biomedical, Inc. (35.87), greater than Lucy Scientific Discovery Inc. (-1.23), greater than Alimera Sciences, Inc. (-20.50), greater than Adamis Pharmaceuticals Corporation (-0.67), less than Shuttle Pharmaceuticals Holdings, Inc. (-0.20), greater than Journey Medical Corporation (-5.03), less than Akanda Corp. (-0.04), greater than Organogenesis Holdings Inc. (-57.13), less than Biofrontera Inc. (-0.45), less than Guardion Health Sciences, Inc. (0.65), greater than China Pharma Holdings, Inc. (-0.69), less than Alkermes plc (14.53), less than Neurocrine Biosciences, Inc. (35.77), greater than Intra-Cellular Therapies, Inc. (-104.38), greater than Deciphera Pharmaceuticals, Inc. (-11.74), less than Dynavax Technologies Corporation (82.22),
Company | PE Ratio | Market cap |
---|---|---|
-0.04 | $4.52M | |
35.87 | $279.89M | |
-1.23 | $906.91K | |
-20.50 | $301.29M | |
-0.67 | $7.25M | |
-0.20 | $2.83M | |
-5.03 | $93.80M | |
-0.04 | $2.20M | |
-57.13 | $399.81M | |
-0.45 | $7.83M | |
0.65 | $4.35M | |
-0.69 | $3.64M | |
14.53 | $4.80B | |
35.77 | $13.82B | |
-104.38 | $9.04B | |
-11.74 | $2.21B | |
82.22 | $1.69B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kala Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kala Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Kala Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Kala Pharmaceuticals, Inc. (KALA)?
What is the highest PE Ratio for Kala Pharmaceuticals, Inc. (KALA)?
What is the 3-year average PE Ratio for Kala Pharmaceuticals, Inc. (KALA)?
What is the 5-year average PE Ratio for Kala Pharmaceuticals, Inc. (KALA)?
How does the current PE Ratio for Kala Pharmaceuticals, Inc. (KALA) compare to its historical average?